Product Center
Products Center
上海阳光医药采购网发布第三批国家药品带量采购相关文件，文件显示，共涉及56个品种，将于2020年8月20日在上海开标。总体来看，集采规则跟第二批带量采购文件比较接近。从而进一步降低群众用药负担。
2022-03-22
The four seasons look at the flowers and the flowers are not old, and the spring moon on a river is Kunming. Sponsored by the Chinese Society of Traditional Chinese Medicine, the Pediatric Branch of the Chinese Society of Traditional Chinese Medicine, the Pediatric School Inheritance and Innovation Community of the Chinese Society of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, and the First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, "the thirty-eighth Pediatric Branch of the Chinese Society of Traditional Chinese Medicine" This academic conference" will be held in Kunming, Spring City from December 10th to 12th, 2021.
2021-12-14
Objective: To observe the clinical efficacy of Bairui granule combined with ribavirin in the treatment of seasonal influenza in children. Methods: 60 children with seasonal influenza were randomly divided into observation group and There were 30 cases in the control group. The children in the control group were treated with ribavirin aerosol, and the observation group was additionally treated with Bairui granules on the basis of the control group. Time to disappearance of symptoms and efficacy. Results: The total effective rate in the observation group was 96. 67%, the total effective rate of the control group was 86. 67%, there was no significant difference between the two groups ( P > 0. 05); There was a statistically significant difference between the two groups (P < 0.05). The disappearance time of clinical symptoms of fever, throat swelling, cough, headache and general pain in the observation group was longer than that in the observation group. The control group was significantly shortened (P < 0.05 or P < 0.01). Conclusion: Bairui granule combined with ribavirin is effective in treating seasonal influenza in children.
2021-10-20
Objective: To observe the clinical efficacy of Bairui Granules in the adjuvant treatment of acute upper respiratory tract infection in children. Methods: 180 children with acute upper respiratory tract infection were randomly divided into two groups. There were 90 cases in the control group and the observation group. On the basis of conventional treatment, the control group was given ribavirin 10 mg·kg - 1 ·d-1 , qd, the observation group was given Bairui Keli on the basis of the control group grain. The clinical efficacy, improvement time of main clinical symptoms and signs, hospital stay and adverse drug reactions were compared between the two groups. Results: Except for the disappearance time of rales, the clinical symptoms of the observation group were The improvement time of physical signs and hospital stay were significantly shorter than those of the control group ( P ＜ 0. 05 ) ; the markedly effective and total effective rates of the observation group were significantly higher than those of the control group ( P ＜ 0. 05 ). Two groups of drugs There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: The adjuvant treatment of Bairui Granules in children with acute upper respiratory tract infection can significantly improve the symptoms of children. It has obvious curative effect and is worthy of clinical promotion.
2021-10-20
